Condition
Influenza With Pneumonia
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.9% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results67% success
Data Visualizations
Phase Distribution
1Total
P 2 (1)
Trial Status
Completed2
Terminated1
Unknown1
Recruiting1
Trial Success Rate
66.7%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT04530799CompletedPrimary
Prospective Observational Trial of IAPA
NCT06202521Phase 2Terminated
CX-4945 in Viral Community Acquired Pneumonia
NCT03748069RecruitingPrimary
Influenza Associated Aspergillosis In-depth Investigation
NCT03391492CompletedPrimary
Invasive Pulmonary Aspergillosis Complicating Influenza Infection
NCT04313946Unknown
Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays
Showing all 5 trials